
Sign up to save your podcasts
Or


Rajeev Ronanki, CEO of Lyric and former Elevance Health executive, unpacks what the FDA’s AI initiative—Elsa—really means for drug innovation and regulation. Rajeev outlines how the agency can use data it already has to drive smarter, faster decisions. He draws powerful parallels to autonomous vehicles and urges the FDA to embrace AI while maintaining scientific rigor.
By Tensor Black4.3
1414 ratings
Rajeev Ronanki, CEO of Lyric and former Elevance Health executive, unpacks what the FDA’s AI initiative—Elsa—really means for drug innovation and regulation. Rajeev outlines how the agency can use data it already has to drive smarter, faster decisions. He draws powerful parallels to autonomous vehicles and urges the FDA to embrace AI while maintaining scientific rigor.

30,681 Listeners

1,932 Listeners

30,200 Listeners

3,348 Listeners

9,628 Listeners

8,522 Listeners

7,235 Listeners

1,835 Listeners

803 Listeners

29,188 Listeners

15,859 Listeners

616 Listeners